PHATHOM PHARMACEUTICALS, INC. Increase (Decrease) in Other Noncurrent Assets
PHATHOM PHARMACEUTICALS, INC. (PHAT) reported Increase (Decrease) in Other Noncurrent Assets of $171.00 thousand for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-07-30.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInOtherNoncurrentAssets · last filed 2026-07-30
- PHATHOM PHARMACEUTICALS, INC. increase (decrease) in other noncurrent assets for the quarter ending 2026-06-30 was $0.00.
- PHATHOM PHARMACEUTICALS, INC. increase (decrease) in other noncurrent assets for the quarter ending 2026-03-31 was $171.00K.
- PHATHOM PHARMACEUTICALS, INC. increase (decrease) in other noncurrent assets for the quarter ending 2025-06-30 was $0.00.
- PHATHOM PHARMACEUTICALS, INC. increase (decrease) in other noncurrent assets for the quarter ending 2025-03-31 was $0.00.
- PHATHOM PHARMACEUTICALS, INC. increase (decrease) in other noncurrent assets for fiscal 2025 was $1.22M.
- PHATHOM PHARMACEUTICALS, INC. increase (decrease) in other noncurrent assets for fiscal 2024 was $0.00, a 100.00% decline from fiscal 2023.
- PHATHOM PHARMACEUTICALS, INC. increase (decrease) in other noncurrent assets for fiscal 2023 was $1.39M, a 1081.36% increase from fiscal 2022.
- PHATHOM PHARMACEUTICALS, INC. increase (decrease) in other noncurrent assets for fiscal 2022 was $118.00K.
| Period end | Increase (Decrease) in Other Noncurrent Assets 3 month | Increase (Decrease) in Other Noncurrent Assets 3 month as first filed | Increase (Decrease) in Other Noncurrent Assets 6 month | Increase (Decrease) in Other Noncurrent Assets 6 month as first filed | Increase (Decrease) in Other Noncurrent Assets 9 month | Increase (Decrease) in Other Noncurrent Assets 9 month as first filed | Increase (Decrease) in Other Noncurrent Assets 12 month | Increase (Decrease) in Other Noncurrent Assets 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2026-07-30 | $171.00K 10-Q · filed 2026-07-30 | ||||||
| 2026-03-31 | $171.00K 10-Q · filed 2026-04-30 | |||||||
| 2025-12-31 | $1.22M 10-K · filed 2026-02-26 | |||||||
| 2025-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2026-07-30 | $0.00 10-Q · filed 2026-07-30 | $0.00 derived: sum of 3 quarters · filed 2026-07-30 | |||||
| 2025-03-31 | $0.00 10-Q · filed 2026-04-30 | $0.00 derived: sum of 2 quarters · filed 2026-04-30 | ||||||
| 2024-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $0.00 10-K · filed 2026-02-26 | ||||||
| 2024-09-30 | $0.00 10-Q · filed 2024-11-07 | |||||||
| 2023-12-31 | -$2.06M derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-06 | $1.39M 10-K · filed 2025-03-06 | ||||||
| 2023-09-30 | $3.45M 10-Q · filed 2024-11-07 | |||||||
| 2022-12-31 | -$1.00K derived: 10-K/A 12 month − 10-Q 9 month · filed 2024-06-14 | -$1.00K derived: sum of 2 quarters · filed 2024-06-14 | $1.00K derived: sum of 3 quarters · filed 2024-06-14 | $118.00K 10-K/A · filed 2024-06-14 | ||||
| 2022-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-09 | $2.00K derived: sum of 2 quarters · filed 2023-11-09 | $119.00K 10-Q · filed 2023-11-09 | $464.00K 10-Q · filed 2022-11-08 | -$41.00K derived: sum of 4 quarters · filed 2023-11-09 | |||
| 2022-06-30 | $2.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-10 | $119.00K 10-Q · filed 2023-08-10 | $464.00K 10-Q · filed 2022-08-02 | -$41.00K derived: sum of 3 quarters · filed 2023-08-10 | $9.00K derived: sum of 4 quarters · filed 2023-08-10 | |||
| 2022-03-31 | $117.00K 10-Q · filed 2023-05-10 | $464.00K 10-Q · filed 2022-05-10 | -$43.00K derived: sum of 2 quarters · filed 2023-05-10 | $7.00K derived: sum of 3 quarters · filed 2023-05-10 | -$87.00K derived: sum of 4 quarters · filed 2023-05-10 | |||
| 2021-12-31 | -$160.00K derived: 10-K 12 month − 10-Q/A 9 month · filed 2023-02-28 | -$110.00K derived: sum of 2 quarters · filed 2023-02-28 | -$204.00K derived: sum of 3 quarters · filed 2023-02-28 | -$203.00K 10-K · filed 2023-02-28 | -$43.00K 10-K · filed 2022-03-01 | |||
| 2021-09-30 | $50.00K derived: 10-Q/A 9 month − 10-Q 6 month · filed 2022-11-09 | -$44.00K derived: sum of 2 quarters · filed 2022-11-09 | -$43.00K 10-Q/A · filed 2022-11-09 | -$40.00K derived: sum of 4 quarters · filed 2022-11-09 | ||||
| 2021-06-30 | -$94.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-02 | -$93.00K 10-Q · filed 2022-08-02 | -$90.00K derived: sum of 3 quarters · filed 2022-08-02 | -$90.00K derived: sum of 4 quarters · filed 2022-08-02 | ||||
| 2021-03-31 | $1.00K 10-Q · filed 2022-05-10 | $4.00K derived: sum of 2 quarters · filed 2022-05-10 | $4.00K derived: sum of 3 quarters · filed 2022-05-10 | $4.00K derived: sum of 4 quarters · filed 2022-05-10 | ||||
| 2020-12-31 | $3.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-01 | $3.00K derived: sum of 2 quarters · filed 2022-03-01 | $3.00K derived: sum of 3 quarters · filed 2022-03-01 | $203.00K 10-K · filed 2022-03-01 | ||||
| 2020-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-08 | $0.00 derived: sum of 2 quarters · filed 2021-11-08 | $200.00K 10-Q · filed 2021-11-08 | |||||
| 2020-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-10 | $200.00K 10-Q · filed 2021-08-10 | ||||||
| 2020-03-31 | $200.00K 10-Q · filed 2021-05-11 | |||||||
| 2019-12-31 | $181.00K 10-K · filed 2021-03-30 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Altimmune, Inc. (ALT) | United States | $0.593B | -6.43 |
| Monopar Therapeutics (MNPR) | United States | $0.598B | -34.82 |
| CytomX Therapeutics, Inc. (CTMX) | United States | $0.598B | -10.25 |
| CorMedix Inc. (CRMD) | United States | $0.605B | 3.25 |
| Aquestive Therapeutics, Inc. (AQST) | United States | $0.606B | -6.67 |
| Indaptus Therapeutics, Inc. (INDP) | United States | $0.537B | |
| IMPACT BIOMEDICAL INC. (IBO) | United States | $0.611B | 66.47 |
| CRESCENT BIOPHARMA, INC. (CBIO) | United States | $0.529B | -5.20 |
| Evolus, Inc. (EOLS) | United States | $0.519B | -13.32 |
| Neurogene Inc. (NGNE) | $0.625B | -4.46 |